Medicyte Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.75 M
- Revenue Growth 37.20%
- Profit Growth -66.91%
- Ebitda -18.92%
- Net Worth 10.84%
- Total Assets 155.37%
About Medicyte Pharmaceutical
Medicyte Pharmaceutical Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 July 2016 (Eight years and seven months 22 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.75 M.
Ashok Tetgure, Shailesh Gharat, Sudhir Marne, and One other member serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999MH2016PTC283228
- Company No.
283228
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medicyte Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Tetgure  | Director | 04-Jul-2016 | Current |
| Shailesh Gharat | Director | 04-Jul-2016 | Current |
| Sudhir Marne | Director | 04-Jul-2016 | Current |
| Shirish Chavan | Director | 01-Dec-2020 | Current |
Financial Performance of Medicyte Pharmaceutical.
Medicyte Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.2% increase. The company also saw a substantial fall in profitability, with a 66.91% decrease in profit. The company's net worth Soared by an impressive increase of 10.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicyte Pharmaceutical?
Unlock access to Medicyte Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.75 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.39 Cr
- Axis Bank Limited : 0.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2023 | Others | ₹3.95 M | Open |
| 09 Mar 2022 | Axis Bank Limited | ₹3.80 M | Open |
How Many Employees Work at Medicyte Pharmaceutical?
Unlock and access historical data on people associated with Medicyte Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicyte Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicyte Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.